SCHEMBL6745925

SCHEMBL6745925

CC(C)(C)c1c(-c2cccc(-c3ccccn3)n2)sc(-c2cccc(-c3ccccn3)n2)c1C(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.58
CCR1 P32246 3/20 0.58
CCR5 P51681 3/20 0.58
CCR8 P51685 3/20 0.58
LMNA P02545 3/20 0.58
TP53 P04637 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
ALOX15 P16050 2/20 0.58
HTT P42858 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
ALPL P05186 1/20 0.58
HSP90AA1 P07900 1/20 0.58
ALPI P09923 1/20 0.58
ALPG P10696 1/20 0.58
MAPK1 P28482 1/20 0.58
CYP1A2 P05177 1/20 0.45
POLB P06746 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6747696 0.81 KDM4E (0.69) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL6744919 0.78 HPGDS (0.43) KDM4ECCR1CCR5CCR8LMNA
Terpyridine SCHEMBL30610403 0.76 KDM4E (0.90) KDM4ECCR1CCR5CCR8LMNA
Terpyridine SCHEMBL57442 0.76 KDM4E (1.00) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL30172832 0.76 KDM4E (1.00) KDM4ECCR1CCR5CCR8LMNA
Terpyridine SCHEMBL29357603 0.76 KDM4E (1.00) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL7964803 0.76 KDM4E (1.00) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL4949169 0.75 KDM4E (0.60) KDM4ECCR1CCR5CCR8LMNA
SCHEMBL6743314 0.74 KDM4E (0.58) KDM4ECCR1CCR5CCR8LMNA
Terpyridine SCHEMBL7112915 0.74 KDM4E (0.95) KDM4ECCR1CCR5CCR8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696182-B2 HIGH PERFORMANCE DIPYRIDYL THIOPHENE OR DIPYRIDYL THIOPHENE DIOXIDE ELECTRON TRANSPORT MATERIALS WHICH WHEN EMPLOYED CAN GIVE LOW-VOLTAGE, HIGH EFFICIENCY ORGANIC ELECTROLUMINESCENT DEVICES CHISSO CORPORATION (JP) 2004-02-24 US disclosed
EP-1186605-B1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORP (JP) 2003-04-16 EP disclosed
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-21 US disclosed
EP-1186605-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative LAGE3, MAL2, ELF3 KDM4E 276/4885CCR1 545/4885CCR5 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.